Bambusa Therapeutics Insider Trades
NASDAQ: BBTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 6 · $58.64M
- Sales
- 0 · $0
- Shares bought / sold
- 3.70M / 0
- Net activity
- Net buying $58.6 million
Bambusa Therapeutics insider activity
Over the last 12 months, Bambusa Therapeutics insiders reported 12 transactions on SEC Form 4: 6 open-market purchases and 0 sales. Insiders bought $58.6 million and sold $0 worth of stock, for net insider buying of $58.6 million. The most recent filing shows RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M. (Director) reporting a transaction in 3,144,858 shares on Nov 2, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BBTX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
BBTX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 2, 2026 | Xu Shanshan & MiNeng, Inc.See remarks | Conversion | 147,238 | — | Form 4 |
| Nov 2, 2026 | Xu Shanshan & MiNeng, Inc.See remarks | Conversion | 16,358 | — | Form 4 |
| Nov 2, 2026 | Jeggle Helmut WolfgangDirector | Buy | 375,000 | $6.00M | Form 4 |
| Nov 2, 2026 | Jeggle Helmut WolfgangDirector | Conversion | 4,769,701 | — | Form 4 |
| Nov 2, 2026 | Salvia Investment GmbH10% Owner | Buy | 375,000 | $6.00M | Form 4 |
| Nov 2, 2026 | Salvia Investment GmbH10% Owner | Conversion | 4,769,701 | — | Form 4 |
| Nov 2, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 164,891 | $2.64M | Form 4 |
| Nov 2, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 2,335,109 | $37.36M | Form 4 |
| Nov 2, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Conversion | 1,331,080 | — | Form 4 |
| Nov 2, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Conversion | 3,144,858 | — | Form 4 |
| Oct 30, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 263,911 | $3.94M | Form 4 |
| Oct 30, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 189,909 | $2.70M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4